Pegus Cheryl 4
4 · Phreesia, Inc. · Filed Dec 18, 2020
Insider Transaction Report
Form 4
Pegus Cheryl
Director
Transactions
- Sale
Common Stock
2020-12-17$56.15/sh−8,415$472,492→ 16,775 total - Exercise/Conversion
Common Stock
2020-12-16$11.89/sh+20,764$246,884→ 47,922 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-12-16−20,764→ 21,332 totalExercise: $11.89Exp: 2029-06-19→ Common Stock (20,764 underlying) - Sale
Common Stock
2020-12-16$55.83/sh−22,732$1,269,089→ 25,190 total
Footnotes (4)
- [F1]A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU respesents a contingent right to receive one share of the Issuer's common stock.
- [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.75 to $56.18 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.80 to $56.655 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]50% of this option vested and became exercisable on May 23, 2020, with the remainder vesting in three substantially equal installments thereafter.